Evaluación y validación de los monitores Omron Hem 705 CP y Hem 706/711 para automedidas de presión arterial

Artigao, L.M.; Llavador, J.J.; Puras, A; Abril, Juan López; Rubio, M.P. Talavera; Torres, Carlos; Vidal, A.; Sánchis, Carlos; Divisón, J.A.; Naharro, Fernando García; Caldevilla, D.; Fuentes, González

doi:10.1016/s0212-6567(00)78470-8

Cited by 68 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Investigators reviewed medical records at baseline and yearly thereafter to assess medical diagnoses. Nurses measured weight and height using standardized procedures, and blood pressure using a validated [ 51 ] semiautomatic oscillometer in triplicate (Omron HEM_705CP). Primary care doctors assessed participants for new diagnoses of hypercholesterolemia, hypertension and type 2 diabetes.…”

Section: Methodsmentioning

confidence: 99%

Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial

Downer

Gea

Stampfer

et al. 2016

Int J Behav Nutr Phys Act

View full text Add to dashboard Cite

BackgroundDietary intervention success requires strong participant adherence, but very few studies have examined factors related to both short-term and long-term adherence. A better understanding of predictors of adherence is necessary to improve the design and execution of dietary intervention trials. This study was designed to identify participant characteristics at baseline and study features that predict short-term and long-term adherence with interventions promoting the Mediterranean-type diet (MedDiet) in the PREvención con DIeta MEDiterránea (PREDIMED) randomized trial.MethodsAnalyses included men and women living in Spain aged 55–80 at high risk for cardiovascular disease. Participants were randomized to the MedDiet supplemented with either complementary extra-virgin olive oil (EVOO) or tree nuts. The control group and participants with insufficient information on adherence were excluded. PREDIMED began in 2003 and ended in 2010. Investigators assessed covariates at baseline and dietary information was updated yearly throughout follow-up. Adherence was measured with a validated 14-point Mediterranean-type diet adherence score. Logistic regression was used to examine associations between baseline characteristics and adherence at one and four years of follow-up.ResultsParticipants were randomized to the MedDiet supplemented with EVOO (n = 2,543; 1,962 after exclusions) or tree nuts (n = 2,454; 2,236 after exclusions). A higher number of cardiovascular risk factors, larger waist circumference, lower physical activity levels, lower total energy intake, poorer baseline adherence to the 14-point adherence score, and allocation to MedDiet + EVOO each independently predicted poorer adherence. Participants from PREDIMED recruiting centers with a higher total workload (measured as total number of persons-years of follow-up) achieved better adherence. No adverse events or side effects were reported.ConclusionsTo maximize dietary adherence in dietary interventions, additional efforts to promote adherence should be used for participants with lower baseline adherence to the intended diet and poorer health status. The design of multicenter nutrition trials should prioritize few large centers with more participants in each, rather than many small centers.Trial registrationThis study was registered at controlled-trials.com (http://www.controlled-trials. com/ISRCTN35739639). International Standard Randomized Controlled Trial Number (ISRCTN): 35739639. Registration date: 5 October 2005.Trial design: parallel randomized trial.Electronic supplementary materialThe online version of this article (doi:10.1186/s12966-016-0394-6) contains supplementary material, which is available to authorized users.

show abstract

Section: Methodsmentioning

confidence: 99%

Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial

Downer

Gea

Stampfer

et al. 2016

Int J Behav Nutr Phys Act

View full text Add to dashboard Cite

show abstract

“…According to a protocol already published by our group [ 35 ], patients recorded their morning, afternoon, and evening home BPs for 4 up to 5 consecutive days in a duplicated fashion with a 1-minute difference between readings, after 5 minutes of rest in the sitting position with an oscillometric device (Omron HEM-705CP, Omron Corp., Tokyo, Japan), previously validated according to the British Hypertension Society (BHS) standards [ 36 ], using the appropriate cuff size. They were instructed on how to perform these measurements by technician staff members and brought home a standardized leaflet with indications which reminded them to perform the measurements as follows: (1) on awakening before breakfast, before antihypertensive drug intake, and after morning micturition, (2) in the afternoon within a 4-hour period starting at 2 p.m., and (3) in the evening before supper, not before 8 p.m.…”

Section: Methodsmentioning

confidence: 99%

Determinants of the Morning-Evening Home Blood Pressure Difference in Treated Hypertensives: The HIBA-Home Study

Aparicio

Barochiner

Cuffaro

et al. 2014

International Journal of Hypertension

View full text Add to dashboard Cite

Background. The morning home blood pressure (BP) rise is a significant asymptomatic target organ damage predictor in hypertensives. Our aim was to evaluate determinants of home-based morning-evening difference (MEdiff) in Argentine patients. Methods. Treated hypertensive patients aged ≥18 years participated in a cross-sectional study, after performing home morning and evening BP measurement. MEdiff was morning minus evening home average results. Variables identified as relevant predictors were entered into a multivariable linear regression analysis model. Results. Three hundred sixty-seven medicated hypertensives were included. Mean age was 66.2 (14.5), BMI 28.1 (4.5), total cholesterol 4.89 (1.0) mmol/L, 65.9% women, 11.7% smokers, and 10.6% diabetics. Mean MEdiff was 1.1 (12.5) mmHg systolic and 2.3 (6.1) mmHg diastolic, respectively. Mean self-recorded BP was 131.5 (14.1) mmHg systolic and 73.8 (7.6) mmHg diastolic, respectively. Mean morning and evening home BPs were 133.1 (16.5) versus 132 (15.7) systolic and 75.8 (8.4) versus 73.5 (8.2) diastolic, respectively. Significant beta-coefficient values were found in systolic MEdiff for age and smoking and in diastolic MEdiff for age, smoking, total cholesterol, and calcium-channel blockers. Conclusions. In a cohort of Argentine medicated patients, older age, smoking, total cholesterol, and use of calcium channel blockers were independent determinants of home-based MEdiff.

show abstract

“…Systolic and diastolic BP were taken in the left arm using an Omron automated BP cuff (HEM-711 DLX and M6 Comfort) [26–28] . BP was taken after participants were seated for five minutes with an appropriately sized cuff.…”

Section: Methods and Subjectsmentioning

confidence: 99%

Effects of a 6-Month Walking Study on Blood Pressure and Cardiorespiratory Fitness in U.S. and Swedish Adults: ASUKI Step Study

Soroush¹,

Ananian²,

Ainsworth³

et al. 2013

Asian J Sports Med

View full text Add to dashboard Cite

Purpose: The aim of this study was to assess the effects of a six-month pedometerbased workplace intervention on changes in resting blood pressure (BP) and cardiorespiratory fitness (CRF). Methods: A subsample of ASUKIStep participants (n= 355) were randomly selected to have changes in their BP and CRF monitored during the intervention. Pedometers were used to monitor steps taken with a goal of walking more than 10,000 steps/day. Systolic and diastolic BP were taken using an Omron automated BP cuff. Estimated VO 2 max was obtained using the Åstrand-Rhyming cycle ergometer test. A multi-level growth modeling approach, and a mixed model ANOVA were used to predict changes in systolic and diastolic BP, and estimated VO 2 max over time by steps, age, gender, and university site. Results:Steps/day averaged 12,256 (SD=3,180) during month 1 and steadily decreased to month 6. There were significant linear and quadratic trends in systolic and diastolic BP over time. Age was positively related to initial starting values for systolic and diastolic BP, and approached significance for systolic BP changes over time. Steps/day approached significance for linear changes in systolic BP. There was a significant difference between ASU and KI participants' estimated VO 2 max. There was a significant change over time in the estimated VO 2 max. The number of steps taken was significantly related to changes in estimated VO 2 max over time. Conclusions:The results of the present study indicate that healthy individuals who took part in a pedometer intervention improved several cardiovascular disease risk factors.

show abstract

Evaluación y validación de los monitores Omron Hem 705 CP y Hem 706/711 para automedidas de presión arterial

Abstract: On the basis of these results, we conclude both monitors Omron HEM 706/711 and the Omron 705CP surpassed the accuracy criteria required for BHS and AAMI, and can be recommended for clinical use.

Cited by 68 publications

References 13 publications

Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial

Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial

Determinants of the Morning-Evening Home Blood Pressure Difference in Treated Hypertensives: The HIBA-Home Study

Effects of a 6-Month Walking Study on Blood Pressure and Cardiorespiratory Fitness in U.S. and Swedish Adults: ASUKI Step Study

Contact Info

Product

Resources

About